2015
DOI: 10.1134/s107042721506004x
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization, and antibacterial activities of some metal complexes of heptadentate schiff base ligand derived from acetylacetone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…In the biological field, there are more attempts to create novel transition metal complexes. Novel chemotherapeutic medicines must be created because many pathogenic germs have become resistant to already available antibacterial medications [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…In the biological field, there are more attempts to create novel transition metal complexes. Novel chemotherapeutic medicines must be created because many pathogenic germs have become resistant to already available antibacterial medications [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Synthesis, characterization of Schiff bases have remained studied is proved that C=N linkage in Schiff bases is an essential part for bioactivity [10]. Schiff bases are significant in many fields, and great assortment in their varied biological activities [11][12][13]. Their role as antimicrobials, and other biological activities like anticancer, antioxidant, anti-tumor and…”
Section: Introductionmentioning
confidence: 99%
“…While there are already several classes of antibacterial agents, there has been some considerable emerging resistance in most pathogenic bacteria to these drugs [18]. For prevention of this serious medical problem, it is necessary to develop some new antibacterial agents or to expand the bioactivity of the previously used drugs [19,20]. Metal-based antibacterial compounds seem to be a promising research for designing a novel therapeutic methodology for new antibiotic drugs to control and prevent the growth of bacterial strains [21,22].…”
Section: Introductionmentioning
confidence: 99%